The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicentered randomized phase II comparison of single-agent carboplatin versus the combination of carboplatin and everolimus for the treatment of advanced triple-negative breast cancer.
 
Jami Aya Fukui
No Relationships to Disclose
 
Charles L. Shapiro
No Relationships to Disclose
 
Meng Ru
No Relationships to Disclose
 
Paula Klein
No Relationships to Disclose
 
Julie Fasano
Consulting or Advisory Role - Magellan Health
 
Aarti Bhardwaj
No Relationships to Disclose
 
Hanna Irie
Research Funding - Cynvenio Biosystems; Ono Pharmaceutical
 
John P. Mandeli
No Relationships to Disclose
 
Anupama Goel
No Relationships to Disclose
 
Neha Kumarley
No Relationships to Disclose
 
Joni Gomes
No Relationships to Disclose
 
Nicholas Shuman
No Relationships to Disclose
 
Damien Francois
No Relationships to Disclose
 
Amy Tiersten
Honoraria - Amgen; Tesaro
Consulting or Advisory Role - AstraZeneca; Eisai; Immunomedics; Novartis; Puma Biotechnology; Roche/Genentech
Speakers' Bureau - Amgen; tesaro
Research Funding - AstraZeneca; pfizer
Travel, Accommodations, Expenses - Amgen; tesaro